Editorial
Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction
| The first 150 words of the full text of this article appear below. |
Both
the recent Institute of Medicine (IOM) report1 and the
article by Henningfield and Fagerstrom2 in this issue of Tobacco Control consider the value of adding
harm reduction products to the main public health strategies for
dealing with tobacco use
prevention, cessation, and protection of
non-smokers from tobacco smoke pollution.3 4 Harm
reducing products are those that lower total tobacco caused morbidity
and mortality, even though these products might involve continued
exposure to one or more tobacco related toxicants. The IOM committee
developed a testing strategy to assess which products (tobacco or
pharmaceutical) are truly harm reducing, along with surveillance and
regulatory principles for the protection of public health. Henningfield
and Fagerstrom2 discussed the possible benefits from an
uncontrolled harm reduction "intervention" in Sweden involving Snus
(Swedish moist snuff) and to some extent nicotine replacement
pharmaceuticals or medicinal nicotine (MN).
It will take years, if ever, before any battery of IOM-type
This article has been cited by other articles:
-
Kozlowski, L. T
(2008). The proposed tobacco regulation: the triumph of hope over experience?. Tobacco Control
17: 74-75
[Full Text] -
Ayo-Yusuf, O A, Reddy, P S, van den Borne, B W
(2008). Association of snuff use with chronic bronchitis among South African women: implications for tobacco harm reduction. Tobacco Control
17: 99-104
[Abstract] [Full Text] -
Eissenberg, T
(2006). The time for tobacco industry sponsored PREP evaluation has arrived. Tobacco Control
15: 1-2
[Full Text] -
Lewis, S, Arnott, D, Godfrey, C, Britton, J
(2005). Public health measures to reduce smoking prevalence in the UK: how many lives could be saved?. Tobacco Control
14: 251-254
[Abstract] [Full Text] -
Kozlowski, L T, Edwards, B Q
(2005). "Not safe" is not enough: smokers have a right to know more than there is no safe tobacco product. Tobacco Control
14: ii3-ii7
[Abstract] [Full Text] -
Maziak, W, Ward, K D, Afifi Soweid, R A, Eissenberg, T
(2004). Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemic. Tobacco Control
13: 327-333
[Abstract] [Full Text] -
Giovino, G. A.
(2004). TOBACCO HARM REDUCTION INVOLVES MORE THAN CIGARETTE HARM REDUCTION. AJPH
94: 1294-1294
[Full Text] -
Joseph, A M, Hennrikus, D, Thoele, M J, Krueger, R, Hatsukami, D
(2004). Community tobacco control leaders' perceptions of harm reduction. Tobacco Control
13: 108-113
[Abstract] [Full Text] -
Martin, E G, Warner, K E, Lantz, P M
(2004). Tobacco harm reduction: what do the experts think?. Tobacco Control
13: 123-128
[Abstract] [Full Text] -
Ayo-Yusuf, O A, Swart, T J P, Pickworth, W B
(2004). Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tobacco Control
13: 186-189
[Abstract] [Full Text] -
Kozlowski, L T, O'Connor, R J, Quinio Edwards, B
(2003). Some practical points on harm reduction: what to tell your lawmaker and what to tell your brother about Swedish snus. Tobacco Control
12: 372-373
[Full Text] -
Warner, K E, Martin, E G
(2003). The US tobacco control community's view of the future of tobacco harm reduction. Tobacco Control
12: 383-390
[Abstract] [Full Text] -
Sumner, W II
(2003). Estimating the health consequences of replacing cigarettes with nicotine inhalers. Tobacco Control
12: 124-132
[Abstract] [Full Text] -
Gray, N., Kozlowski, L. T.
(2003). More on the regulation of tobacco smoke: how we got here and where next. Ann Oncol
14: 353-357
[Abstract] [Full Text] -
Kozlowski, L T
(2003). First, tell the truth: a dialogue on human rights, deception, and the use of smokeless tobacco as a substitute for cigarettes. Tobacco Control
12: 34-36
[Abstract] [Full Text] -
Farone, W A
(2002). Harm reduction: 25 years later. Tobacco Control
11: 287-288
[Full Text] -
Kozlowski, L T, O'Connor, R J
(2002). Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents. Tobacco Control
11: i40-50
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
